Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 534

1.

The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.

Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA.

Interact Cardiovasc Thorac Surg. 2010 Feb;10(2):200-3. doi: 10.1510/icvts.2009.220392. Epub 2009 Nov 19.

3.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
4.

Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.

Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):615-9. doi: 10.1016/j.jtcvs.2007.09.029. Epub 2008 Jan 11.

PMID:
18329480
5.

Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.

Perigaud C, Bridji B, Roussel JC, Sagan C, Mugniot A, Duveau D, Baron O, Despins P.

Eur J Cardiothorac Surg. 2009 Oct;36(4):731-6. doi: 10.1016/j.ejcts.2009.05.044. Epub 2009 Jul 25.

PMID:
19632852
6.

Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?

Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E.

Thorac Cardiovasc Surg. 2012 Mar;60(2):116-21. doi: 10.1055/s-0030-1271148. Epub 2011 Jun 20.

PMID:
21692019
7.

The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.

Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.

Clin Nucl Med. 2007 Aug;32(8):607-12.

PMID:
17667432
8.

Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.

Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, Young V.

Eur J Cardiothorac Surg. 2008 Jan;33(1):104-9. Epub 2007 Oct 30.

PMID:
17977738
9.

PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.

Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P; Groupe d'Oncologie Thoracique des Cliniques Saint-Luc.

Eur J Cardiothorac Surg. 2001 Sep;20(3):468-74; discussion 474-5.

PMID:
11509265
10.

Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer.

Melek H, Gunluoglu MZ, Demir A, Akin H, Olcmen A, Dincer SI.

Eur J Cardiothorac Surg. 2008 Feb;33(2):294-9. Epub 2007 Dec 21.

PMID:
18096398
11.

Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.

Lee BE, von Haag D, Lown T, Lau D, Calhoun R, Follette D.

J Thorac Cardiovasc Surg. 2007 Mar;133(3):746-52.

PMID:
17320577
12.
13.

Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer?

Iskender I, Kadioglu SZ, Kosar A, Atasalihi A, Kir A.

Interact Cardiovasc Thorac Surg. 2011 Jun;12(6):965-9. doi: 10.1510/icvts.2010.258103. Epub 2011 Mar 25.

14.

The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.

Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA.

Ann Thorac Surg. 2004 Sep;78(3):1017-23; discussion 1017-23.

PMID:
15337041
16.

Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes.

Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V.

Lung Cancer. 2008 Apr;60(1):62-8. Epub 2007 Oct 24.

PMID:
17920724
17.

[The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].

Melek H, Günlüoğlu MZ, Demir A, Akin H, Medetoğlu B, Kara HV, Olçmen A, Dinçer SI.

Tuberk Toraks. 2008;56(1):56-63. Turkish.

PMID:
18330756
18.

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.

Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30.

PMID:
10536941
19.

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.

Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL, Verschakelen JA, Lerut TE, Mortelmans LA, Demedts MG.

J Clin Oncol. 1998 Jun;16(6):2142-9.

PMID:
9626214
20.

Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.

Aquino SL, Asmuth JC, Alpert NM, Halpern EF, Fischman AJ.

J Comput Assist Tomogr. 2003 Jul-Aug;27(4):479-84.

PMID:
12886128
Items per page

Supplemental Content

Write to the Help Desk